ESR1 and breast cancer: Interestingly, it has been reported that anabolic and androgenic endocrine treatments (e.g., tamoxifen or aromatine inhibitors) and bilateral oophorectomy may be used to limit estrogen synthesis or impede the activation of estrogen receptors in BC cells that are positive for estrogen receptors (the ER+ subtype) [82].